高质量发展中药配方颗粒——关于四部门联合发布《关于结束中药配方颗粒试点工作的公告》的思考

High Quality Development of Traditional Chinese Medicine Formula Granules-Thoughts on the Announcement on Ending the Pilot Work of Traditional Chinese Medicine Formula Granules Jointly Issued by Four Departments

2021年2月1日,国家药品监督管理局、国家中医药管理局、国家卫生健康委员会和国家医疗保障局四部门联合发布了《关于结束中药配方颗粒试点工作的公告》,标志着中药配方颗粒试点工作圆满结束,为配方颗粒高质量发展奠定基础,指明了方向。为此,总结近年来国家药品监督管理局、国家药典委员会和试点企业在结束中药配方颗粒试点工作方面所做的工作,为中药配方颗粒未来发展提供参考。

On February 1,2021,the State Food and Drug Administration,the State Administration of Traditional Chinese Med-icine,the State Health Commission and the State Medical Insurance Administration jointly issued the announcement on Ending the Pilot Work of Traditional Chinese Medicine Formula Granules,which marked the successful conclusion of the pilot work of traditional Chinese medicine formula granules,pointed out the direction and laid the foundation for the future high-quality development of formula granules.Therefore,summarize the work done by the State Food and drug administration,Pharmaco-poeia Commission and pilot enterprises in the end of the pilot work of traditional Chinese medicine formula particles in recent years to express gratitude and firm confidence in the future development of traditional Chinese medicine formula granules.It will contribute to the high-quality development of traditional Chinese medicine formula granules and the modernization of tradi-tional Chinese medicine.